Objectives: Effective disinfection and antisepsis is pivotal in preventing infections within the healthcare setting. Chlorhexidine digluconate (CHG) is a widely used disinfectant/antiseptic possessing broad-spectrum antimicrobial activity; however, its penetration into bacterial biofilms and human skin is poor. The aim of this study was to investigate the antimicrobial efficacy of crude eucalyptus oil (EO) and its main component 1,8-cineole (a recognized permeation enhancer), alone and in combination with CHG, against a panel of clinically relevant microorganisms grown in planktonic and biofilm cultures.
Introduction
Incision of human skin is common practice within the healthcare setting, for example during surgery and insertion of indwelling medical devices such as central venous catheters. 1, 2 Infectious complications that may arise following skin incision are well documented and are commonly caused by transient or resident skin microorganisms such as coagulase-negative staphylococci (CoNS), in particular Staphylococcus epidermidis, as well as Pseudomonas aeruginosa and Candida albicans. 3, 4 Infections arising from these microorganisms are further complicated by their ability to produce biofilms, which result in reduced permeation of antimicrobials. 5, 6 Adequate and effective skin antisepsis is therefore pivotal in the prevention of such infections. Whilst a range of skin antiseptics is currently available for use within the clinical setting, recent EPIC2 recommendations favour the routine use of 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol (IPA). 7 CHG possesses broad bactericidal activity against many Gram-positive and Gram-negative bacteria, as well as C. albicans. 8 Despite the proven antimicrobial activity of CHG, recent research has demonstrated that both aqueous and alcoholic preparations of CHG poorly penetrate human skin, allowing microorganisms residing in the deeper layers of the skin to survive current recommendations for antisepsis. 9, 10 Hence, there is a clear need for novel agents and improved strategies to enhance skin antisepsis. The antimicrobial efficacy of many essential oils has been known for many years. 11 Research recently undertaken within our department has demonstrated that eucalyptus oil (EO) in particular, not only possesses antimicrobial activity against S. epidermidis existing in planktonic and biofilm modes of growth, but also has synergistic antimicrobial activity when combined with CHG against biofilms of S. epidermidis. 12 In addition, more recent research has demonstrated that EO significantly enhances the permeation of alcoholic and aqueous CHG into the deeper layers of human skin, compared with alcoholic and aqueous preparations of CHG alone (data not shown). Based on these recent findings, crude EO has the potential for combination with CHG in the development of a formulation for improved skin antisepsis.
There are numerous constituents within crude EO that may contribute to its overall antimicrobial efficacy including 1,8-cineole, camphene, a-pinene, globulol and limonene, 13 though these vary with season and between species of eucalyptus. 14 The major component of crude EO is 1,8-cineole (eucalyptol), which ranges in percentage composition from 44.3% to 84.4% 13, 15 and is known to possess antimicrobial properties, as well as being a penetration enhancer for topical delivery to the skin. 16 Acting on the stratum corneum of the skin, 1,8-cineole temporarily disrupts the intercellular lipids, allowing entry into the skin of otherwise poorly penetrable substances. 16 Combining CHG with either crude EO or indeed its major component alone, 1,8-cineole, may therefore offer a potential novel strategy for enhanced skin antisepsis.
The production of an antiseptic or disinfectant for potential use within a clinical setting can be broadly split into two phases; discovery and development. This encompasses toxicological and pharmacokinetic investigations, along with refinement of the product. 17 The aim of this current investigation was to compare the antimicrobial efficacy of crude EO with its major constituent 1,8-cineole alone and in combination with CHG, against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), P. aeruginosa, Escherichia coli and C. albicans, when grown in planktonic and biofilm modes of growth. The results of this investigation will determine whether the minor constituents of EO contribute to the overall antimicrobial efficacy of crude EO, or whether a refined formulation comprising CHG and 1,8-cineole alone may be adopted. 
Materials and methods

Preparation of microorganisms for suspension tests
Overnight suspensions of each test microorganism were prepared following inoculation of MHB or SDB with five identical colonies from MHA or SDA. Using optical density (OD) at 570 nm, the concentration of microorganism in each overnight suspension was determined using previously established OD/concentration standard curves. The suspensions were then diluted in MHB or SDB as required to generate a final concentration of 1Â10 7 cfu/mL.
Determination of MICs and MBCs of aqueous CHG, EO and 1,8-cineole for microorganisms in suspension
To determine the MICs of aqueous CHG, EO and 1,8-cineole, microbroth dilution assays were performed in line with CLSI (formerly NCCLS) guidelines. 18 Each well contained 100 mL of test antimicrobial (CHG 128-0.125 mg/L, EO 512-0.25 g/L and 1,8-cineole 512-0.25 g/L) and 100 mL of microbial suspension diluted in MHB or SDB, containing 1Â10 5 cfu. Plates were incubated in air for 24 h at 378C. The MIC was then determined visually as the lowest concentration showing no growth. The MBC was determined by mixing the entire contents of each well (200 mL) with molten Letheen broth containing 1% (w/v) agar No. 1, cooled to 508C. After setting, the plates were incubated for 24 h in air at 378C, or 48 h in air at 308C for C. albicans. The MBC was identified as the lowest concentration plated to show no microbial growth. The assay was repeated in triplicate.
Chequerboard assay to assess the antimicrobial activity of CHG in combination with EO and 1,8-cineole against microorganisms in suspension
The antimicrobial activity of CHG in combination with EO and 1,8-cineole was assessed against each microorganism in suspension, by use of chequerboard assays performed in duplicate in line with the method described by Shin and Lim. 19 After preparing serial double dilutions of each antimicrobial (CHG 128 -0.125 mg/L, EO 512-0.5 g/L and 1,8-cineole 512 -2 g/L) 100 mL of CHG was added to the columns of a 96-well microtitre plate in decreasing concentrations and 100 mL of EO or 1,8-cineole added in reducing concentrations to the rows. Wells were then inoculated with 10 mL of the test microorganism to provide 10 5 microorganisms per well. Control wells containing each agent individually in MHB or SDB were incorporated and inoculated as described previously. Following 24 h of incubation in air at 378C or 308C for C. albicans, the MIC of each agent alone and in combination was determined as described previously. 
Establishment of microbial biofilms
For each microorganism, the OD of the overnight suspension was determined at 570 nm and diluted in MHB or SDB as required to a final concentration of 1Â10 5 cfu/mL. Using previously established optimum conditions for biofilm development (data not shown) biofilms of each microorganism were grown in clear flat-bottomed, tissue culture-treated 6-well microtitre plates. Confirmation of biofilm production by each test microorganism was achieved by applying Alcian Blue stain to each of the wells. 21 To confirm slime production, microorganisms were cultured onto Congo Red agar. 22 Confluent biofilms were subsequently generated in wells of whitewalled, clear bottom, tissue culture-treated 96-well microtitre plates, inoculated with 200 mL of a 1Â10 5 cfu/mL suspension of each microorganism. Empty wells were reserved for use as negative controls. Microtitre plates were then incubated in air for 48 h at 378C or 308C (for C. albicans). (Previous experiments established that biofilms contained $1Â10 7 cfu/mL S. aureus, $1Â10 9 cfu/mL MRSA, $1Â10
10 cfu/mL P. aeruginosa, $1Â10 10 cfu/mL E. coli and $5Â10
5 cfu/mL C. albicans.)
Determination of MICs and MBCs of CHG, EO and 1,8-cineole for microorganisms in biofilm To triplicate wells, 100 mL MHB or SDB was added to 100 mL of antimicrobial agent in decreasing concentrations across the rows. After 24 h of incubation in air at 378C or 308C for C. albicans, the antimicrobial agents were removed and the wells washed once with PBS.
PBS (250 mL) was added to each well and the plate sonicated at 50 Hz in a water bath for 30 min at room temperature. Biofilms were recovered from the wells by a scrape and wash procedure 23 and the entire contents of the well (250 mL) mixed with molten Letheen broth containing 1% (w/v) agar No. 1, cooled to 508C. Following incubation of the set plates in air at 378C or 308C (for C. albicans) for 24 h, the MIC was determined as the lowest concentration to show growth below or equal to that of the control (biofilm in saline). The MBC was identified as the lowest concentration demonstrating no bacterial growth.
Chequerboard assay to assess the antimicrobial activity of CHG in combination with EO and 1,8-cineole against microorganisms in biofilm
Biofilms of each test microorganism were grown in white-walled, clear bottom, tissue culture-treated 96-well microtitre plates then gently washed once with PBS to remove unbound cells. CHG, EO and 1,8-cineole were diluted as described previously and 125 mL of CHG added to the columns, decreasing in concentration with each column, and 125 mL of EO or 1,8-cineole added in decreasing concentrations to the rows. The plates were incubated in air at either 378C or 308C (for C. albicans) for 24 h. Following incubation, all CHG, EO and 1,8-cineole was removed from the wells and ATP bioluminescence was used to determine the microbial viability. 12 The MIC was determined as the minimum concentration to produce a level of luminescence less than or equal to that of the control (biofilm in saline), and the MBC as the concentration giving luminescence below or equal to the background luminescence (empty well). The assay was performed in duplicate microtitre plates.
Results
Determination of MICs and MBCs of CHG, EO and 1,8-cineole for microorganisms in suspension and biofilm DMSO used at 5% (v/v) in oil suspensions showed no antimicrobial activity against the five test microorganisms in suspension or biofilm (data not shown). Antimicrobial activity was demonstrated by EO, 1,8-cineole and CHG against suspensions and biofilms of S. aureus, MRSA, P. aeruginosa, E. coli and C. albicans (Table 1) . Crude EO was shown to possess significantly more antimicrobial activity compared with 1,8-cineole (P,0.05) against microorganisms grown in suspension, while CHG revealed significantly more antimicrobial activity than EO (P, 0.05) against both bacterial suspension and biofilm. EO showed a ,1-fold increase on average between the bacteriostatic and bactericidal concentrations against suspensions; however, there was a 1-to 2-fold increase between the MIC and MBC values observed with 1,8-cineole. P. aeruginosa demonstrated decreased susceptibility to EO, 1,8-cineole and CHG in suspension and biofilm when compared with the other test microorganisms.
Chequerboard assay to assess the antimicrobial activity of CHG in combination with EO and 1,8-cineole against microorganisms in suspension and biofilm (Table 2 ). When applied to biofilms, combinations of CHG with EO and 1,8-cineole demonstrated synergy against MRSA and P. aeruginosa; however, CHG and EO against E. coli resulted in indifference with an FICI value of 0.750. Indifference was also demonstrated with the combination of CHG and 1,8-cineole against S. aureus and C. albicans with FICI values of 0.625 and 1.125, respectively (Table 3) .
Discussion
The aim of this current study was to investigate the antimicrobial properties of crude EO and its main component 1,8-cineole, alone and in combination with aqueous CHG, when applied to microorganisms in suspension and biofilm modes of growth. The results showed that there were differing degrees of antimicrobial activity of EO, 1,8-cineole and CHG against test microorganisms, in both modes of growth. In addition, CHG combined with both EO and 1,8-cineole demonstrated synergistic antimicrobial activity in some cases.
Bacterial biofilms are well reported to exhibit increased resistance to antimicrobial agents compared with their planktonic counterparts, due in part to the physical barrier they create. 24, 25 This makes biofilms particularly important in clinical settings as their removal presents many difficulties, while their presence often creates serious complications with regard to patient management.
Many novel and alternative agents have been investigated for their potential antimicrobial properties and essential oils are no exception, with tea tree oil, rosemary, clove, thymol and EO being some of those more commonly tested. 11 The results of this study concur with previous research, verifying that EO and its main component, 1,8-cineole, both possess antimicrobial activity; 26 such properties were also confirmed for CHG. However, in line with research by Karpanen et al., 12 there was also a notable difference in efficacy between the oils and CHG (EO and cineole in the order of g/L, CHG in the order of mg/L).
Comparing the antimicrobial properties of crude EO with those of 1,8-cineole alone confirmed the importance of other constituents contained within EO in relation to the MIC/MBC values obtained. Whilst both the crude oil and 1,8-cineole possessed activity, the MIC/MBC concentrations of 1,8-cineole were equal to or greater than those of EO in all cases except for biofilm growth of C. albicans where 1,8-cineole was more efficacious. Therefore it appears that while 1,8-cineole may be largely responsible for the antimicrobial activity associated with EO, other minor constituents contribute. Lachowicz et al. 27 reported similar results for the antimicrobial properties of crude basil oil and its two main components linalool and methyl chavicol.
Synergistic activity was observed for CHG in combination with either crude EO or 1,8-cineole against all test microorganisms grown in suspension with the exception of P. aeruginosa, where indifference was concluded. In the biofilm mode of growth, antimicrobial synergy was also observed in all microorganisms, with indifference determined for CHG and EO against E. coli, as well as CHG and 1,8-cineole against S. aureus and C. albicans. It is likely that the synergy observed is due to the target sites of the agents. The main target of CHG is the cytoplasmic membrane, which is also the same target site of EO and cineole, resulting in damaged structural stability of the cell, leading in turn to increased permeability. 28, 29 In conclusion, the results from this study demonstrate the potential for combining CHG with either crude EO or its major constituent 1,8-cineole for enhanced, synergistic antimicrobial activity against a wide range of clinically relevant microorganisms in planktonic or biofilm modes of growth. However, the superior antimicrobial efficacy associated with crude EO alone, compared with 1,8-cineole, favour its combination with CHG for further research. Additional investigations are currently underway.
Funding
This work was supported by an Engineering and Physical Sciences Research Council (EPSRC) CASE studentship (voucher number: 07001671) and industrial contribution from Insight Health Ltd, UK.
